ESTA - Establishment Labs Holdings Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
27.02
-0.39 (-1.42%)
As of 2:23PM EST. Market open.
Stock chart is not supported by your current browser
Previous Close27.41
Open27.20
Bid26.88 x 800
Ask27.03 x 1200
Day's Range26.72 - 27.37
52 Week Range16.55 - 30.06
Volume41,298
Avg. Volume94,483
Market Cap556.626M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-2.09
Earnings DateNov 11, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est39.50
  • Establishment Labs Holdings Inc. (ESTA): Hedge Fund Sentiment Unchanged
    Insider Monkey

    Establishment Labs Holdings Inc. (ESTA): Hedge Fund Sentiment Unchanged

    With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second quarter. One of these stocks was Establishment Labs Holdings Inc. (NASDAQ:ESTA). Establishment Labs Holdings Inc. (NASDAQ:ESTA) […]

  • GlobeNewswire

    ESTA Reaches One Million Motiva Implants Milestone

    Establishment Labs Holdings Inc. (ESTA), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – announced its one millionth Motiva® implant in market. Most importantly, we achieved this milestone while maintaining less than a 1% complication rate for events related to Motiva Implants®.

  • Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Tops Revenue Estimates
    Zacks

    Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Tops Revenue Estimates

    Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of -19.23% and 14.27%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Establishment Labs Reports Third Quarter 2019 Financial Results

    NEW YORK, Nov. 12, 2019 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and.

  • GlobeNewswire

    Establishment Labs is Presenting at Two November Investor Conferences

    Stephens Nashville Conference on November 13Jefferies 2019 London Healthcare Conference on November 21 NEW YORK, Nov. 07, 2019 -- Establishment Labs Holdings Inc. (NASDAQ:.

  • Analysts Estimate Establishment Labs Holdings Inc. (ESTA) to Report a Decline in Earnings: What to Look Out for
    Zacks

    Analysts Estimate Establishment Labs Holdings Inc. (ESTA) to Report a Decline in Earnings: What to Look Out for

    Establishment Labs Holdings Inc. (ESTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Hedge Funds Have Never Been Less Bullish On Establishment Labs Holdings (ESTA)
    Insider Monkey

    Hedge Funds Have Never Been Less Bullish On Establishment Labs Holdings (ESTA)

    We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 45% and 39% respectively. Hedge funds' top 3 stock picks returned 34.4% this year and beat the S&P […]

  • GlobeNewswire

    Establishment Labs to Announce Third Quarter 2019 Financial Results on November 12, 2019

    Establishment Labs Holdings Inc. (ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced the Company will release its financial results for the third quarter ended September 30, 2019, before the market opens on Tuesday, November 12, 2019. Establishment Labs will host a webcast the same day at 8:30 a.m. Eastern Time to discuss the results. The webcast will be available for 30 days following the call on the Investor Relations section of the Company's website at www.establishmentlabs.com.

  • If You Had Bought Establishment Labs Holdings (NASDAQ:ESTA) Stock A Year Ago, You'd Be Sitting On A 17% Loss, Today
    Simply Wall St.

    If You Had Bought Establishment Labs Holdings (NASDAQ:ESTA) Stock A Year Ago, You'd Be Sitting On A 17% Loss, Today

    Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. But if...

  • GlobeNewswire

    Establishment Labs Recaps Fifth Annual World Symposium on Ergonomic Implants

    Establishment Labs Holdings Inc. (ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today provided a recap of the Fifth Annual World Symposium on Ergonomic Implants, which was held October 3-5, 2019 in Lago di Garda, Italy. The annual symposium, hosted by Establishment Labs, is a world-class medical education event held to promote the evolution of breast surgical techniques and breast implant technology. “Medical education events like our annual World Symposium are critical to our efforts to raise awareness for the need to improve safety and aesthetic outcomes in breast aesthetics and reconstruction and we are very pleased with this year’s record attendance,” said Juan José Chacón-Quirós, Chief Executive Officer of Establishment Labs.“ Against a challenging industry backdrop, driven by heightened safety concerns around textured and polyurethane implants, this World Symposium’s medical education program provides us with a platform from which to demonstrate the advanced technology and science behind Motiva Implants® to highly regarded plastic surgeons from around the world, reinforcing our commitment to women’s health.

  • 3 Stocks Thriving on Competitors' Failures
    GuruFocus.com

    3 Stocks Thriving on Competitors' Failures

    Finding your edge is key for any brand that’s trying to compete in a crowded sector, and knowing where other companies fall short Continue reading...

  • Establishment Labs Poised to Capitalize on Allergan Breast Implant Issues
    GuruFocus.com

    Establishment Labs Poised to Capitalize on Allergan Breast Implant Issues

    Costa Rican company’s technology believed to cause fewer complications Continue reading...

  • GlobeNewswire

    Establishment Labs Receives Notice of Allowance for Key U.S. Patent Application Covering Company’s Implant Surface Technology and Announces 510(k) Submission for its Tissue Expander

    Establishment Labs Holdings Inc. (ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that the Company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for a key patent application covering its proprietary implant surface technology. Acquired from the University of Manchester, this critical research and patent application was funded with the cooperation of Establishment Labs and is an important component of Motiva Implants®.

  • Does Establishment Labs Holdings (NASDAQ:ESTA) Have A Healthy Balance Sheet?
    Simply Wall St.

    Does Establishment Labs Holdings (NASDAQ:ESTA) Have A Healthy Balance Sheet?

    The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

  • GlobeNewswire

    Establishment Labs to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference

    NEW YORK, Aug. 28, 2019 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and.

  • Establishment Labs Holdings Inc (ESTA) Q2 2019 Earnings Call Transcript
    Motley Fool

    Establishment Labs Holdings Inc (ESTA) Q2 2019 Earnings Call Transcript

    ESTA earnings call for the period ending June 30, 2019.

  • Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates
    Zacks

    Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates

    Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of 15.38% and 7.88%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Establishment Labs Reports Second Quarter 2019 Financial Results

    NEW YORK, Aug. 13, 2019 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and.

  • Earnings Preview: Establishment Labs Holdings Inc. (ESTA) Q2 Earnings Expected to Decline
    Zacks

    Earnings Preview: Establishment Labs Holdings Inc. (ESTA) Q2 Earnings Expected to Decline

    Establishment Labs Holdings Inc. (ESTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire

    Establishment Labs to Announce Second Quarter 2019 Financial Results on August 13, 2019

    Establishment Labs Holdings Inc. (ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced the Company will release its financial results for the second quarter ended June 30, 2019, before the market opens on Tuesday, August 13, 2019. Establishment Labs will host a webcast the same day at 8:30 a.m. Eastern Time to discuss the results. The webcast will be available for 30 days following the call on the Investor Relations section of the Company's website at www.establishmentlabs.com.

  • Do Insiders Own Shares In Establishment Labs Holdings Inc. (NASDAQ:ESTA)?
    Simply Wall St.

    Do Insiders Own Shares In Establishment Labs Holdings Inc. (NASDAQ:ESTA)?

    A look at the shareholders of Establishment Labs Holdings Inc. (NASDAQ:ESTA) can tell us which group is most powerful...

  • GlobeNewswire

    Establishment Labs Announces Additional Financing and Improved Terms with Amendment to Existing Credit Agreement

    Establishment Labs Holdings Inc. (ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it has entered into an amendment to its existing credit agreement (the “Credit Agreement”) with affiliates of Madryn Asset Management, LP, (“Madryn”) effective June 17, 2019. The amended terms of the Credit Agreement, which was originally entered into on August 24, 2017, provides Establishment Labs with up to $25 million in new borrowing capacity from Madryn to increase the company’s financial flexibility.  The amended Credit Agreement extends the maturity date on all loans to a full repayment on September 30, 2025, reduces the interest rate on all loans from LIBOR plus 11% per annum down to LIBOR plus 8% per annum, and modifies certain other terms and provisions.

  • GlobeNewswire

    Establishment Labs Holdings Inc. and Allergan Sales, LLC Extend Distribution and Supply Agreement for MotivaImagine® Insertion Sleeve

    Establishment Labs Holdings Inc. (ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it has reached an agreement with Allergan Sales, LLC to extend an agreement to import, sell and distribute the MotivaImagine® Insertion Sleeve across the agreed upon countries as part of the MotivaImagine® suite of products for breast surgery. Using best-in-class technology, the MotivaImagine® Insertion Sleeve is a surgical tool that assists plastic surgeons with a no touch effortless implant insertion process with Motiva Implants®. It is one of the components of the MotivaImagine® ecosystem, partnering Establishment Labs with plastic surgery centers in more than 70 countries worldwide.

  • Business Wire

    Glancy Prongay & Murray LLP Announces Investigation on Behalf of Establishment Labs Holdings Inc. Investors (ESTA)

    Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Establishment Labs Holdings Inc. (“Establishment Labs” or the “Company”) (NASDAQ: ESTA) investors concerning the Company and its officers’ possible violations of federal securities laws. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. On April 10, 2019, Seeking Alpha published an article, alleging in relation to the Company’s accounting, “near-zero product return allowance, extremely high levels of inventory, several going concern clauses, a peripatetic CEO and a physically detached CFO.” In addition to these claims, the article also alleged that the Company provided inaccurate information to both the SEC and investors.

  • GlobeNewswire

    Establishment Labs to Present at Jefferies 2019 Healthcare Conference

    Establishment Labs Holdings Inc. (ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that Chief Executive Officer Juan José Chacón-Quirós will be presenting at the Jefferies Healthcare Conference on June 4, 2019 at 11:30 a.m. Eastern Time. Establishment Labs Holdings Inc. (ESTA) is a global medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform. Motiva Implants® are produced at our two manufacturing sites that are compliant with ISO13485:2016, FDA 21 CFR 820 under the MDSAP program, and are currently commercially available in over 70 countries through exclusive distributors or the Company’s direct salesforce.